In recent years, the rapid development of technology and innovation has sped up the transformation of the healthcare and well-being industry. Among the various emerging and evolving trends, Light T...
In recent years, significant strides have been made in the realm of medical imaging, ushering in a new era of possibilities for healthcare professionals engaged in diagnosing, treating, and monitoring a diverse array of medical conditions and diseases. The convergence and developments in the state-of-the-art techno...
Find More
Sutro Biopharma nets $85.4M to drive antibody-drug conjugates Sutro Biopharma reeled in an $85.4 million series E that will advance some early-stage programs as well as its cancer pipeline, which includes a pair of antibody-drug conjugates (ADCs).Of its ADC assets, STRO-001 is in phase 1 for lymphoma and multiple my...
Find More
The gene therapy in rare diseases market has drastically changed recently due to scientific advancem.....
Find More
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally .....
Find More
Over the years, the Oncology domain has experienced the entry of several treatment approaches. Thera.....
Find More
Acute Respiratory Distress Syndrome (ARDS) is a serious lung condition that causes low blood oxygen......
Find More
Digital health technologies can fill the current gaps in oncology care while rebalancing the existin.....
Find More
Cell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
